ALung Technologies Receives Expedited Access Pathway Designation from FDA for Hemolung Respiratory Assist System

10.04.15

The Expedited Access Pathway Designation for ALung’s Hemolung Respiratory Assist System will facilitate introduction of breakthrough respiratory technology in the U.S.